Observational Study
Copyright ©2016 Baishideng Publishing Group Co.
World J Nephrol. Mar 6, 2016; 5(2): 204-212
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.204
Table 1 Characteristics of peritoneal dialysis patients
Characteristics of patients
Sex (male/female)122/96 (56% male)
Etiology (non-DM/DM)179/36 (17% diabetes)
Age (yr)56 (20, 46, 64, 84)
PD duration (mo)40 (1, 15, 63, 206)
Peritonitis episode (times)0 (0, 0, 1, 9)
D/P Cr0.65 (0.38, 0.59, 0.71, 0.88)
D/D 0 glucose0.40 (0.21, 0.34, 0.44, 0.59)
Table 2 Biomarker levels in the peritoneal effluent
BiomarkerLevel in the peritoneal effluent
Matrix metalloproteinase-2 (ng/mL)159 (14, 107, 220, 681)
Interleukin-6 (pg/mL)14.6 (1.5, 7.6, 29.6, 253.5)
Hyaluronan (ng/mL)109 (5.1, 53, 204, 889)
Cancer antigen 125 (U/mL)6.7 (0.7, 4.0, 12.1, 91.8)
Table 3 Correlation between patient characteristics and effluent biomarker levels
Biomarker levels in the peritoneal effluents
MMP-2IL-6HyaluronanCA125
Sex (male/female)P = 0.92P = 0.54P = 0.48P < 0.05
Etiology (non-DM/DM)P = 0.18P = 1.00P = 0.56P < 0.05
Age (yr)ρ = 0.076ρ = 0.12ρ = 0.046ρ = -0.096
P = 0.27P = 0.092P = 0.50P = 0.16
PD duration (mo)ρ = 0.050ρ = 0.15ρ = 0.25ρ = -0.062
P = 0.47P < 0.05P < 0.01P = 0.93
Peritonitis episode (times)ρ = 0.17ρ = 0.25ρ = 0.092ρ = -0.012
P < 0.05P < 0.001P = 0.20P = 0.86
Table 4 Correlation between effluent biomarker levels and the results of peritoneal equilibration test
D/P CrD/D0 glucoseMMP-2IL-6HyaluronanCA125
D/P Crρ = 1ρ = -0.86ρ = 0.74ρ = 0.46ρ = 0.27ρ = 0.13
P < 0.001P < 0.001P < 0.001P < 0.001P = 0.051
D/D0 Glucoseρ = 1ρ = -0.65ρ = -0.28ρ = -0.22ρ = -0.094
P < 0.001P < 0.001P < 0.005P = 0.19
MMP-2ρ = 1ρ = 0.54ρ = 0.40ρ = 0.1
P < 0.001P < 0.001P < 0.05
IL-6ρ = 1ρ = 0.45ρ = 0.26
P < 0.001P < 0.001
Hyaluronanρ = 1ρ = 0.18
P < 0.01
CA125ρ = 1
Table 5 Test performance of effluent biomarkers cut-off levels to distinguish the high category of peritoneal equilibration test
BiomarkersCut-off levelSensitivity (95%CI)Specificity (95%CI)AUC
MMP-2-214 ng/mL0.95 (0.86 to 1.00)0.79 (0.74 to 0.85)0.90
219 ng/mL0.86 (0.71 to 1.00)0.81 (0.76 to 0.86)
228 ng/mL0.81 (0.62 to 0.95)0.84 (0.79 to 0.89)
238 ng/mL0.76 (0.57 to 0.95)0.87 (0.82 to 0.91)
IL-616.8 pg/mL0.81 (0.62 to 0.95)0.60 (0.53 to 0.67)0.78
19.3 pg/mL0.76 (0.57 to 0.90)0.65 (0.58 to 0.73)
20.0 pg/mL0.71 (0.52 to 0.90)0.66 (0.60 to 0.73)
24.8 pg/mL0.67 (0.48 to 0.86)0.75 (0.66 to 0.79)
Hyaluronan94.5 ng/mL0.81 (0.62 to 0.95)0.47 (0.41 to 0.54)0.62
101.5 ng/mL0.71 (0.52 to 0.90)0.51 (0.44 to 0.58)
108.0 ng/mL0.67 (0.48 to 0.86)0.52 (0.45 to 0.58)
115.0 ng/mL0.62 (0.43 to 0.81)0.53 (0.46 to 0.53)
CA1253.85 U/mL0.81 (0.62 to 0.95)0.23 (0.17 to 0.29)0.51
4.45 U/mL0.71 (0.52 to 0.90)0.30 (0.23 to 0.37)
6.55 U/mL0.62 (0.43 to 0.81)0.50 (0.43 to 0.57)
7.05 U/mL0.52 (0.33 to 0.71)0.53 (0.46 to 0.59)
Table 6 Test performance of effluent matrix metalloproteinase-2 cut-off levels to predict the encapsulating peritoneal sclerosis in peritoneal dialysis patients
Cut-off levelSensitivity (95%CI)Specificity (95%CI)AUC
458.51.00 (1.00 to 1.00)0.96 (0.94 to 0.98)0.99
609.50.88 (0.63 to 1.00)0.99 (0.98 to 1.00)
863.50.63 (0.25 to 0.88)1.00 (0.99 to 1.00)